Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial.

Acta Neuropathol Commun · 2014 · PMC4229733 · PMID 24952577

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In keeping with the results of the main trial, patients with MGMT methylation showed a trend towards better survival on 5-day TMZ rather than 21-day.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.